NovelBeam Technology(SH:688677) Xin Lang Cai Jing·2025-11-27 07:39Core Viewpoint - The company, Haitai New Light, is experiencing growth in revenue and profit, benefiting from the depreciation of the RMB and its status as a "specialized, refined, distinctive, and innovative" enterprise in the medical device sector [2][3][7]. Group 1: Company Performance - Haitai New Light's stock price increased by 0.33% on November 27, with a trading volume of 32.64 million yuan and a market capitalization of 5.446 billion yuan [1]. - For the period from January to September 2025, the company achieved a revenue of 448 million yuan, representing a year-on-year growth of 40.47%, and a net profit attributable to shareholders of 136 million yuan, also showing a growth of 40.03% [7]. - The company's revenue from medical endoscope devices accounts for 64.86% of total revenue, while optical products contribute 21.63% [7]. Group 2: Market Position and Recognition - Haitai New Light is recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is a prestigious title in China for companies excelling in niche markets and possessing strong innovation capabilities [3]. - The company has a vertical integration capability in the medical device industry, covering core components, key equipment, and system integration [2]. Group 3: Financial Metrics and Shareholder Information - As of September 30, the company had 5,188 shareholders, a decrease of 1.84% from the previous period, with an average of 23,106 circulating shares per shareholder, an increase of 1.87% [7]. - The company has distributed a total of 277 million yuan in dividends since its A-share listing, with 207 million yuan distributed over the past three years [8]. - Major shareholders include various funds, with the top ten shareholders holding significant stakes, indicating a stable institutional presence [8][9].